Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novacyt Group

http://novacyt.com

Latest From Novacyt Group

Stock Watch: Dam Cracks After A Trickle Of Failed Pandemic Products

Many of the many biotech companies that raised money to develop and repurpose their molecules to address the pandemic have started to unwind those efforts. What will this mean for the sector’s valuation?

Coronavirus COVID-19 Research & Development

Sir Mene Pangalos Outlines AZ's Trio Of COVID-19 Targets

The diagnostics tie-up with GSK on testing is a near-term move to help the UK get back to normality, the drug major's biopharmaceuticals R&D boss tells Scrip. AstraZeneca's main focus is to develop monoclonal antibodies to tackle 'wave two' of the coronavirus.

Coronavirus COVID-19 Leadership

Fact File: Coronavirus Medtech And Diagnostic Updates

As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.

Coronavirus COVID-19 Commercial

COVID-19 Fact File: Global Diagnostic Test Pipeline

Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.

Coronavirus COVID-19 Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Research, Analytical Equipment & Supplies
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Lab21, Ltd.
    • Primer Design Ltd.
    • IT-IS International Ltd
UsernamePublicRestriction

Register